Stock screenerAll disclosures → EDGAR →
ALVO
Conviction 74HealthcareScan · Thu, Sep 24, 2026Alvotech (ALVO) closed at $5.89 (+1.38%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 73, RS Rating 91, -34.4% from its 52-week high, +17.8% year to date. Sector: Healthcare · Drug Manufacturers - Specialty & Generic.
ALVO$5.89+1.38%
ResistanceSupportVol 14Vol MA14 1.28M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Price5.89
Change+1.38%
Gap+0.00%
Rel volume1.30×
Avg volume1.17M
Avg $ vol6.33M
SMA 205.35
SMA 504.44
SMA 2004.17
Price vs 50+32.61%
Price vs 200+41.19%
MA stackbullish
50/200 crossgolden · 6d
Supertrendup · 5.06
RSI (14)73
MACD hist0.02
MACD crossbull · 3d
Stoch %K / %D85 / 85
ADX (14)43
+DI / −DI37 / 12
RSI divergence—
MACD divergence—
ATR %4.77%
ADR %4.56%
52w high8.98
52w low3.00
From 52w high-34.41%
Above 52w low+96.33%
New 52w highNo
SqueezeOff
Bollinger width23.86%
%B0.92
Donchian pos86.67%
Donchian high6.06
Donchian low4.79
AVWAP (52w high)4.46
vs AVWAP high+32.12%
AVWAP (52w low)4.33
vs AVWAP low+36.10%
OBV trendUp
Chaikin MF (20)0.00
Today vs 20d1.30×
Avg vol (14d)1.28M
Avg vol (20d)1.17M
Avg $ vol (20d)6.33M
Market cap1.84B
RS Rating91 / 99
RS 3m (vs SPY)+64.76%
RS 6m (vs SPY)+70.76%
RS line new highYes
Trend template5/8
Technical rank96.0
1 week+10.30%
1 month+16.63%
3 months+69.25%
6 months+87.58%
1 year-32.30%
YTD+17.80%
P/E—
P/B—
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq—
Current—
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target7.00
Target upside18.85%
Analyst ratingBuy
Institutional12.09%
Ent. value1.84B
Revenue—
Net income—
Gross profit—
Free cash flow—
IndustryDrug Manufacturers - Specialty & Generic
ExchangeNasdaq
Shares out—
Employees1.46K
ListedThu, Jun 16, 2022
Free float115.49M
Float %37.0%
Short interest5.59M
Days to cover4.4d
Short volume41.1%
Squeeze score37 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.11 vs −$0.06
Last surprise-83.3% miss
Setup gradeB
Conviction74 / 100
Pattern quality—
Tech rank96.0 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance5.73
Support3.68
Days since event—
Candle confirm—
Congress activity
Disclosed STOCK Act trades in ALVO
No recent disclosed trades by Congress in ALVO. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in ALVO
No recent insider (Form 4) filings in ALVO. Insiders must file within two business days of a trade.
SEC filings
EDGAR filings in ALVO · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.